560 related articles for article (PubMed ID: 25956311)
1. When can immunotherapy for insect sting allergy be stopped?
Müller UR; Ring J
J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
[TBL] [Abstract][Full Text] [Related]
2. Stinging insect allergy: state of the art 2015.
Tankersley MS; Ledford DK
J Allergy Clin Immunol Pract; 2015; 3(3):315-22; quiz 323. PubMed ID: 25956310
[TBL] [Abstract][Full Text] [Related]
3. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
4. Large local reactions to insect stings.
Golden DB
J Allergy Clin Immunol Pract; 2015; 3(3):331-4. PubMed ID: 25819508
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Hymenoptera venom allergy: an update.
Pesek RD; Lockey RF
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):340-6. PubMed ID: 24887986
[TBL] [Abstract][Full Text] [Related]
6. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
7. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
9. Key Issues in Hymenoptera Venom Allergy: An Update.
Alfaya Arias T; Soriano Gómis V; Soto Mera T; Vega Castro A; Vega Gutiérrez JM; Alonso Llamazares A; Antolín Amérigo D; Carballada Gonzalez FJ; Dominguez Noche C; Gutierrez Fernandez D; Marques Amat L; Martinez Arcediano A; Martinez San Ireneo M; Moreno Ancillo A; Puente Crespo Y; Ruiz Leon B; Sánchez Morillas L;
J Investig Allergol Clin Immunol; 2017; 27(1):19-31. PubMed ID: 28211342
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Hymenoptera venom allergy.
Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
[TBL] [Abstract][Full Text] [Related]
11. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
12. Management of occupational Hymenoptera allergy.
Ruëff F; Chatelain R; Przybilla B
Curr Opin Allergy Clin Immunol; 2011 Apr; 11(2):69-74. PubMed ID: 21368617
[TBL] [Abstract][Full Text] [Related]
13. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
[TBL] [Abstract][Full Text] [Related]
14. Natural history and long-term follow-up of Hymenoptera allergy.
Ruëff F
Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):445-451. PubMed ID: 32739977
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.
Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB
Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
18. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
[TBL] [Abstract][Full Text] [Related]
20. Hymenoptera venom immunotherapy.
Bilò BM; Bonifazi F
Immunotherapy; 2011 Feb; 3(2):229-46. PubMed ID: 21322761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
